Skip to main content
English
English
Arabic
Chinese (Simplified)
French
German
Hindi
Portuguese
Russian
Spanish
Swahili
Header
Contact us
Subscribe to newsletter
https://twitter.com/GlobalHep
https://www.facebook.com/GlobalHep/
https://www.linkedin.com/company/coalition-for-global-hepatitis-elimination
Donate
Add a Program
Add a Program
Profile
Logout
Main navigation
Toggle main menu visibility
About
Who we are
What we do
Our team
Technical Advisory Board
Executive Board
Donor Acknowledgements
CGHE Annual Reports
Annual Report 2022
Annual Report 2021
Annual Report 2020
CGHE Publications
Partner programs
Programs search
Data dashboards
Country data dashboards
National Hepatitis Elimination Profiles
Evidence base
All evidence (search)
Evidence Base Methodology
HCV Treatment in Pregnancy
Tip-HepC Registry
TiP-HepC Systematic Review Results
Scientific Advisory Committee: TipHepC
Action Plan Systematic Review
Hepatitis B Birth Dose Vaccine Systematic Review
Synthesis Brief of Hepatitis B Birth Dose Evidence Base
HCV Testing Systematic Review
COVID-19 Evidence Hub
COVID-19 and Liver Disease Synthesis
Clinical Liver Disease COVID-19 special series
The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
Innovations in Hepatitis Elimination (CLD Series)
Author Interviews
Introduction to Series
Past Publications
Author Guidance
Hepatitis Elimination Help Desk
Resources
Partnering with Civil Society Organizations in Africa to Increase Hepatitis B Birth Dose Vaccination
Report: Sharing Investments in Pandemic Preparedness and Hepatitis Elimination
Expanding access to hepatitis C prevention, testing, and treatment in prisons
Hep C Elimination Tool
Access the Tool
User Guide
Frequently Asked Questions
Technical Assistance Help Desk and Frequently Asked Questions
Toolkit: Birth Dose Vaccination in Africa
Search resources
Elimination champions
Nominations for 2023 Elimination Champions
News
Announcements
US Hepatitis C Elimination Initiative
News search
HepEquity Blog
HepEquity Blog: Caroline Thomas: A Catalyst for Change in Indonesia
HepEquity Blog: Highlights from the CGHE Staff Bibliography
HepEquity Blog: Champions Don’t Wait: Dr. Charles Adjei’s Hepatitis Elimination Efforts in Ghana
HepEquity Blog: Local Hepatitis Elimination and Prevention Program (LHEAP) Launches in Rawalpindi, Pakistan
Elimination Champions
Events
Newsletters
Press releases
Publications
Webinars & Events
HDV Webinar Series
HDV Webinar Series
HCV in Prisons
Treatment of HCV in Pregnancy for Hepatitis (TiP-HepC)
Webinar 1: Challenges
Webinar 2: Strategies
Webinar 3: Recommendations
NIH "Moving from Hepatitis Discovery to Elimination"
Hep Test
Linkage to care
Strategic Information Collaborative
Regional Hepatitis Elimination
HepB Birth Dose Introduction in AFRO
Innovations in Hepatitis Elimination
Search webinars
UN Group of Friends
Toggle search
Keywords
Search
Home
Programs
Programs search
Programs search
Keywords
Search
Clear all
Filter
Burkina Faso
Ethiopia
Gambia
Georgia
Ghana
Indonesia
Malawi
Mongolia
Nigeria
Senegal
South Africa
Sudan
Uganda
United States of America
Viet Nam
Zambia
Facet Program - Country
Blood safety
Coinfection with HIV
Community mobilization
Harm reduction
HBV perinatal screening and prophylaxis
HBV testing and linkage to care
HCV testing and linkage to Care
HCV treatment
Hepatitis B Vaccination
Hep B birth-dose vaccination
Implementation of birth dose vaccination
Implementation of vaccination (general)
Injection safety and infection control
Linkage to care
Persons who inject drugs: HCV cure as prevention
Persons who inject drugs: Medication assisted therapy
Persons who inject drugs: Syringe service program(s)
Prevention mother-child transmission
(-)
Program evaluation
Prophylaxis
Safer injection practices
Safer sex practices
Screening and diagnosis
Screening of pregnant women
Strategic data analysis
Testing
Treatment
Treatment (direct or referral)
Vaccination (general)
Facet Program - Key interventions
Active
Facet Program - Phase
Micro elimination
National
Regional
Facet Program - Setting
Adolescents (10 - 19 years of age)
Adults
Adults (> 19 years of age)
General Population
Immigrants/Refugees
Incarcerated populations (current and former)
Infants (less than one year of age)
Men who have sex with men
Not yet known
Occupations with possible exposure
People experiencing homelessness
Persons who inject drugs
Persons with substance use disorder
Pregnant women
Sexual contact(s)
Young Adults <21
Facet Program - Target populations
Hepatitis B
Hepatitis C
Facet Program - Virus targets
Displaying 1 - 7 of 7
Hepatitis B in Africa Collaborative Research Network (HEPSANET)
African Region
Hepatitis B
Hep Free S-W Organization
African Region
Hepatitis B
Hepatitis C
Georgia National HCV Elimination Program
European Region
Hepatitis B
Hepatitis C
Hepatitis Free Mongolia
Western Pacific Region
Hepatitis B
Hepatitis C
National Task Force on Hepatitis B-- United States
Region of the Americas
Hepatitis B
Bali Peduli -- Indonesia
Western Pacific Region
Hepatitis B
Hepatitis C
Vietnam Viral Hepatitis Alliance (V-VHA)
South-East Asia Region
Hepatitis B
Hepatitis C
